Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (Q43138653)
Jump to navigation
Jump to search
scientific article published in March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment |
scientific article published in March 2010 |
Statements
1 reference
Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (English)
1 reference
1 reference
1 reference
Salim Yusuf
1 reference
Janice Pogue
1 reference
Stefan Hohnloser
1 reference
Campbell Joyner
1 reference
Prem Pais
1 reference
Rafael Diaz
1 reference
Greg Flaker
1 reference
Robert Hart
1 reference
Jack Lawrence
1 reference
David Synhorst
1 reference
Stuart J Connolly
1 reference
1 March 2010
1 reference
1 reference
159
1 reference
3
1 reference
348-353.e1
1 reference
Identifiers
1 reference
1 reference